Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder
Introduction The efficacy and of current antidepressants is insufficient. Esketamine, a new antidepressant administered by nasal route, is available since 2019 in the management of resistant characterized depressive episodes. Objectives To evaluate the response profile of patients to Esketamine in...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Cambridge University Press
2022-06-01
|
| Series: | European Psychiatry |
| Assuntos: | |
| Acceso en liña: | https://www.cambridge.org/core/product/identifier/S0924933822014171/type/journal_article |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|